Published: Guidance, quality standards and advice
Showing 771 to 780 of 2564
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Fremanezumab for preventing migraine | TA764 | ||
| Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable | TA765 | ||
| Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma | TA766 | ||
| Ponesimod for treating relapsing–remitting multiple sclerosis | TA767 | ||
| Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs | TA768 | ||
| Colorectal cancer | QS20 | ||
| Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care | HTG607 | ||
| Glaucoma: diagnosis and management | NG81 | ||
| Rehabilitation after traumatic injury | NG211 | ||
| Smart Peak Flow for monitoring asthma | MIB282 |